Presenting Author: Anna-Belle Beau, PhD – Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, Toulouse, France
Author: Xavier Moisset – Université Clermont Auvergne, CHU de Clermont-Ferrand, Inserm, Neuro-Dol, Clermont-Ferrand
Author: Justine Benevent – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
Author: Marie Beslay, PhD – Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, France.
Author: Claudia C. Bartolini – ARS Toscana
Author: Marie-Agnès Bernard – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France
Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
Author: Mika Gissler, PhD – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki
Author: Sue Jordan, MB.BCh., PhD. PGCE (FE), – Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea
Author: Régis Lassalle, MSc – Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France
Author: Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
Author: Angela Lupattelli, MSc – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
Author: Marco Manfrini – Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University, Italy
Author: Visa Martikainen – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
Author: Joan K. Morris – St George's, University of London, London
Author: Amanda j. Neville, N/A – Registro IMER University of Ferrara and Azienda Ospedaliero Universitario S Anna, Ferrara, Italy
Author: Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
Author: Olga Paoletti – Regional Health Agency of Tuscany, Pharmacoepidemiology Unit, Florence, Italy
Author: Jingping Mo – Worldwide Medical and Safety, Pfizer Inc., New York, NY
Author: Christine Damase-Michel, PhD, PharmD – Université Toulouse III
Presenting Author: Milica Zugic, MScPharm – Department of Pharmacy, University of Oslo, Oslo, Norway
Author: Nhung Trinh, PhD – PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo
Author: Hedvig Nordeng, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
Author: Angela Lupattelli, MSc – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
Presenting Author: Claudia Bruno, BSc(hon) (she/her/hers) – School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
Author: Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
Author: Vidar Hjellvik, PhD – Norwegian Institute of Public Health
Author: Sinna Pilgaard Ulrichsen, MSc (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
Author: Marte-Helene h. Bjørk, MD, PhD – NorHEAD Norwegian Centre for Headache Research, Department of Clinical Medicine, University of Bergen, Bergen, Norway Jonas Lies vei 87 5021, Bergen Norway
Author: Buket Öztürk Esen, MSc – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
Author: Malcolm B. Gillies, PhD (he/him/his) – School of Population Health, University of New South Wales
Author: Mika Gissler, PhD – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki
Author: Alys Havard, PhD (she/her/hers) – National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
Author: Pär Karlsson, MSc (he/him/his) – Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
Author: Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health
Author: Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
Author: Mette Nørgaard, MD, PhD – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
Author: Sallie-Anne Pearson, PhD – School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia
Author: Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
Author: Hein Stigum, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
Author: Kari Furu, PhD – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health
Author: Jacqueline Cohen, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
Author: Helga Zoega – University of New South Wales - Sydney